Variant report
Variant | nsv575467 |
---|---|
Chromosome Location | chr17:46396831-46402212 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:11)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:11 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr17:46399170..46400082-chr17:46670950..46671830,2 | MCF-7 | breast: | |
2 | chr17:46394167..46397926-chr17:46405990..46408451,3 | K562 | blood: | |
3 | chr17:46401524..46403183-chr17:46407797..46409461,2 | K562 | blood: | |
4 | chr17:46398305..46400507-chr17:46409355..46412275,3 | K562 | blood: | |
5 | chr17:46382958..46385585-chr17:46395013..46396995,2 | K562 | blood: | |
6 | chr17:46399623..46402614-chr17:46666348..46668783,2 | K562 | blood: | |
7 | chr17:46399542..46400089-chr17:46662377..46663363,2 | K562 | blood: | |
8 | chr17:46386965..46388989-chr17:46394978..46396866,2 | K562 | blood: | |
9 | chr17:46393909..46396723-chr17:46401139..46403154,2 | K562 | blood: | |
10 | chr17:46391077..46394144-chr17:46396348..46399085,4 | K562 | blood: | |
11 | chr17:46402150..46403911-chr17:46405862..46407499,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000235300 | chromatin interactions |
ENSG00000233101 | chromatin interactions |
ENSG00000120075 | chromatin interactions |
ENSG00000120093 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7206951 | chr17:46396831-46396832 | Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs533874005 | chr17:46396846-46396847 | Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs554364812 | chr17:46396877-46396878 | Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs574165384 | chr17:46396880-46396881 | Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs536925467 | chr17:46396899-46396900 | Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs556608805 | chr17:46396958-46396959 | Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs538953350 | chr17:46396961-46396962 | Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs373068212 | chr17:46397030-46397031 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs147604863 | chr17:46397048-46397049 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs142162056 | chr17:46397087-46397088 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs112902183 | chr17:46397109-46397110 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs541138628 | chr17:46397143-46397144 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs560265375 | chr17:46397161-46397162 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs529104494 | chr17:46397176-46397177 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs148833487 | chr17:46397196-46397197 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs566118856 | chr17:46397214-46397215 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs531330816 | chr17:46397215-46397216 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs143427738 | chr17:46397218-46397219 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs180941620 | chr17:46397262-46397263 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs374023554 | chr17:46397295-46397296 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs533835627 | chr17:46397471-46397472 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs547538950 | chr17:46397475-46397476 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs567828205 | chr17:46397479-46397480 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs536482935 | chr17:46397501-46397502 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs72827830 | chr17:46397502-46397503 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs576710701 | chr17:46397549-46397550 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs183525326 | chr17:46397635-46397636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs142316774 | chr17:46397638-46397639 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs558483303 | chr17:46397730-46397731 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs148382336 | chr17:46397821-46397822 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs190447738 | chr17:46397856-46397857 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs556188327 | chr17:46397858-46397859 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs577749498 | chr17:46397870-46397871 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs561259266 | chr17:46397907-46397908 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs573770121 | chr17:46397914-46397915 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs542503256 | chr17:46397920-46397921 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs71377355 | chr17:46397929-46397930 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs142199699 | chr17:46397939-46397940 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs551712547 | chr17:46397940-46397941 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs564845034 | chr17:46398024-46398025 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs527314613 | chr17:46398042-46398043 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs547502184 | chr17:46398093-46398094 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs35058651 | chr17:46398122-46398123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs397757723 | chr17:46398132-46398133 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs567293142 | chr17:46398143-46398144 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs200009133 | chr17:46398180-46398181 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs550060758 | chr17:46398208-46398209 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs145805222 | chr17:46398251-46398252 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs138444086 | chr17:46398257-46398258 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs182228017 | chr17:46398267-46398268 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Melanoma | 18172304 | CNVD |
Moyamoya disease | 22323933 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Cancer | 16751803 | CNVD |
Chordoma | 21602918 | CNVD |
Neurofibromatosis | 20686819 | CNVD |
Peripheral nerve sheath tumors | 20686819 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Breast cancer | 21264507 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Gastric cancer | 17167181 | CNVD |
Breast cancer | 19287154 | CNVD |
Leukemia | 20874852 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Breast cancer | 17457667 | CNVD |
Breast cancer | 16951389 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 22048815 | CNVD |
Breast cancer | 17603634 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 20953835 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
TAR Syndrome | 17847015 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 19261255 | CNVD |
Lung cancer | 16773561 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Basal-like breast cancer | 18066063 | CNVD |
Breast cancer | 20031965 | CNVD |
Colorectal cancer | 19287155 | CNVD |
Hereditary breast | 19566914 | CNVD |
Ovarian cancer | 19047089 | CNVD |
Ovarian cancer | 19566914 | CNVD |
Triple-negative breast cancer | 18950515 | CNVD |
Breast cancer | 16846527 | CNVD |
Bladder cancer | 21909424 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 16397240 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Prostate cancer | 17217626 | CNVD |
Non-syndromic sensorineural hearing loss | 21084979 | CNVD |
Autism | 22817714 | CNVD |
Breast cancer | 20409316 | CNVD |
Cancer | 17160897 | CNVD |
Frontotemporal lobar degeneration | 19640594 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Breast cancer | 21509527 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Anaplastic thyroid cancer | 18753363 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:46373200-46415000 | Weak transcription | Primary mononuclear cells fromperipheralblood | Blood |
2 | chr17:46375800-46415800 | Weak transcription | Primary T cells effector/memory enriched fromperipheralblood | blood |
3 | chr17:46377200-46421000 | Weak transcription | Primary T killer naive cells fromperipheralblood | blood |
4 | chr17:46386200-46407800 | Weak transcription | Primary T helper cells fromperipheralblood | blood |
5 | chr17:46390200-46429400 | Weak transcription | Primary T killer memory cells from peripheral blood | blood |
6 | chr17:46391000-46410400 | Weak transcription | GM12878-XiMat | blood |
7 | chr17:46391000-46420200 | Weak transcription | Primary B cells from peripheral blood | blood |
8 | chr17:46391200-46421200 | Weak transcription | Primary T helper naive cells from peripheral blood | blood |
9 | chr17:46391400-46405800 | Weak transcription | Primary T helper memory cells from peripheral blood 1 | blood |
10 | chr17:46392200-46399600 | Weak transcription | Primary T helper memory cells from peripheral blood 2 | blood |
11 | chr17:46394000-46400800 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
12 | chr17:46394600-46405400 | Weak transcription | Primary T helper cells PMA-I stimulated | -- |
13 | chr17:46395200-46402800 | Weak transcription | Primary T regulatory cells fromperipheralblood | blood |
14 | chr17:46396200-46406200 | Weak transcription | Primary T helper 17 cells PMA-I stimulated | -- |
15 | chr17:46396200-46421200 | Weak transcription | Primary T helper naive cells fromperipheralblood | blood |
16 | chr17:46396400-46397400 | Strong transcription | Primary T cells fromperipheralblood | blood |
17 | chr17:46396800-46414400 | Weak transcription | Primary T cells from cord blood | blood |
18 | chr17:46397400-46398200 | Weak transcription | Primary T cells fromperipheralblood | blood |
19 | chr17:46398200-46398600 | Strong transcription | Primary T cells fromperipheralblood | blood |
20 | chr17:46398600-46407600 | Weak transcription | Primary T cells fromperipheralblood | blood |
21 | chr17:46399600-46399800 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
22 | chr17:46399800-46405800 | Weak transcription | Primary T helper memory cells from peripheral blood 2 | blood |
23 | chr17:46400800-46405600 | Strong transcription | Primary Natural Killer cells fromperipheralblood | blood |